Phase I/II Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer
Phase of Trial: Phase I/II
Latest Information Update: 08 Mar 2018
At a glance
- Drugs LOAd 703 (Primary)
- Indications Adenocarcinoma; Biliary cancer; Colorectal cancer; Fallopian tube cancer; Ovarian cancer; Pancreatic cancer; Peritoneal cancer
- Focus Adverse reactions
- Sponsors Lokon Pharma
- 01 Mar 2018 Planned End Date changed from 1 Nov 2020 to 1 Dec 2022.
- 01 Mar 2018 Planned primary completion date changed from 1 May 2020 to 31 Dec 2020.
- 01 Mar 2018 Status changed from not yet recruiting to recruiting.